Feedback / Questions
IkT-148009 - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-reports-second-quarter-2022-financial-results-and-highlights-recent-period-activity-301605200.html
Aug 12, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next